Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis

F. D'Addio, V. A. Valderrama, M. Ben Nasr, E. Franek, D. Zhu, L. Li, G. Ning, E. Snarski, P. Fiorina

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)S72-S73
JournalDiabetes Technology and Therapeutics
Volume18
DOIs
Publication statusPublished - Feb 1 2016

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

D'Addio, F., Valderrama, V. A., Ben Nasr, M., Franek, E., Zhu, D., Li, L., Ning, G., Snarski, E., & Fiorina, P. (2016). Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: A multicenter analysis. Diabetes Technology and Therapeutics, 18, S72-S73. https://doi.org/10.1089/dia.2016.2507